脑电图分析和阿尔茨海默病的鉴定:一篇综述
Jinying Bi1, Fei Wang1, Fangzhou Hu1
1Faculty of Robot Science and Engineering, Northeastern University, Shenyang, China.
Frontiers in aging neuroscience
|December 25, 2025
概括
电脑电图 (EEG) 分析是诊断阿尔茨海默病 (AD) 的有希望的工具. 本综述综合了141项关于EEG在AD研究中的应用研究,突出了关键方法和未来方向.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 医疗信息学 医疗信息学
背景情况:
- 阿尔茨海默病 (AD) 对患者,家庭和社会构成重大挑战.
- 准确的诊断和AD的分析对于有效的管理至关重要.
- 脑电图 (EEG) 可以直接测量大脑活动,使其成为AD研究的焦点.
研究的目的:
- 审查和分析EEG在阿尔茨海默病研究中的应用.
- 将现有文献分类,并确定关键研究主题和趋势.
- 为研究EEG-AD关系的研究人员和临床医生提供参考资料.
主要方法:
- 在谷歌学者和PubMed.Med的系统文献搜索.
- 根据出版时间对141篇相关文章进行了选和分类.
- 对受试者类型的分析,实验设计,电极选择,文物处理,节奏划分,特征提取和识别方法.
主要成果:
- 基于EEG的AD识别是一个活跃的研究领域,采用了多种不同的方法.
- 分析的关键方面包括实验设计,数据处理和特征提取技术.
- 该审查整合了发现,强调了研究优先事项,并讨论了一致的结果.
结论:
- 脑电图显示出作为阿尔茨海默病诊断和分析的生物标志物的巨大潜力.
- 进一步的研究应侧重于改进方法和验证EEG发现.
- 脑电图 (EEG) 是一种有价值的,非侵入性的工具,用于了解AD,并了解未来的发展趋势.
更多相关视频
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.1K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.5K
相关概念视频
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744